Literature DB >> 30267958

Hierarchical structured and programmed vehicles deliver drugs locally to inflamed sites of intestine.

Wei Li1, Yunzhan Li2, Zehua Liu1, Nattha Kerdsakundee3, Ming Zhang2, Feng Zhang1, Xueyan Liu2, Tomás Bauleth-Ramos4, Wenhua Lian2, Ermei Mäkilä5, Marianna Kemell6, Yaping Ding1, Bruno Sarmento7, Ruedeekorn Wiwattanapatapee8, Jarno Salonen5, Hongbo Zhang9, Jouni T Hirvonen1, Dongfei Liu10, Xianming Deng11, Hélder A Santos12.   

Abstract

Orally administrable drug delivery vehicles are developed to manage incurable inflammatory bowel disease (IBD), however, their therapeutic outcomes are compromised by the side effects of systemic drug exposure. Herein, we use hyaluronic acid functionalized porous silicon nanoparticle to bridge enzyme-responsive hydrogel and pH-responsive polymer, generating a hierarchical structured (nano-in-nano-in-micro) vehicle with programmed properties to fully and sequentially overcome the multiple obstacles for efficiently delivering drugs locally to inflamed sites of intestine. After oral administration, the pH-responsive matrix protects the embedded hybrid nanoparticles containing drug loaded hydrogels against the spatially variable physiological environments of the gastrointestinal tract until they reach the inflamed sites of intestine, preventing premature drug release. The negatively charged hybrid nanoparticles selectively target the inflamed sites of intestine, and gradually release drug in response to the microenvironment of inflamed intestine. Overall, the developed hierarchical structured and programmed vehicles load, protect, transport and release drugs locally to inflamed sites of intestine, contributing to superior therapeutic outcomes. Such strategy could also inspire the development of numerous hierarchical structured vehicles by other porous nanoparticles and stimuli-responsive materials for the local delivery of various drugs to treat plenty of inflammatory gastrointestinal diseases, including IBD, gastrointestinal cancers and viral infections.
Copyright © 2018 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Drug delivery; Hybrid nanoparticle; Porous silicon; Stimuli responsive; Targeting

Mesh:

Substances:

Year:  2018        PMID: 30267958     DOI: 10.1016/j.biomaterials.2018.09.024

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  5 in total

Review 1.  Recent advances in hybrid system of porous silicon nanoparticles and biocompatible polymers for biomedical applications.

Authors:  Yuna Jung; Dokyoung Kim
Journal:  Biomed Eng Lett       Date:  2021-06-15

2.  Garcinol Encapsulated Ph-Sensitive Biodegradable Nanoparticles: A Novel Therapeutic Strategy for the Treatment of Inflammatory Bowel Disease.

Authors:  Eden Mariam Jacob; Ankita Borah; Sindhu C Pillai; D Sakthi Kumar
Journal:  Polymers (Basel)       Date:  2021-03-11       Impact factor: 4.329

Review 3.  Recent Progress in the Diagnosis and Precise Nanocarrier-Mediated Therapy of Inflammatory Bowel Disease.

Authors:  Liucan Wang; Min Yu; Hua Yang
Journal:  J Inflamm Res       Date:  2021-04-29

4.  Laser-Induced Nanodroplet Injection and Reconfigurable Double Emulsions with Designed Inner Structures.

Authors:  Jin-Kun Guo; Seung-Ho Hong; Hyun-Jin Yoon; Greta Babakhanova; Oleg D Lavrentovich; Jang-Kun Song
Journal:  Adv Sci (Weinh)       Date:  2019-07-03       Impact factor: 16.806

Review 5.  Exploitation of Marine-Derived Robust Biological Molecules to Manage Inflammatory Bowel Disease.

Authors:  Muhammad Bilal; Leonardo Vieira Nunes; Marco Thúlio Saviatto Duarte; Luiz Fernando Romanholo Ferreira; Renato Nery Soriano; Hafiz M N Iqbal
Journal:  Mar Drugs       Date:  2021-03-30       Impact factor: 5.118

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.